I built a coding tutor that won't let me cheat my way through it. Here's the prompt.

Adobe today launched its most ambitious AI offensive to date, unveiling the Firefly AI Assistant — a new agentic creative tool that can orchestrate complex, multi-step workflows across the company's ...

Gen. Stephen Whiting noted the number of personnel at Redstone is expected to grow to nearly 200 by the end of 2026. (Staff Sgt. Kirsten Brandes/U.S. Space Force) U.S. Space Command is operating a ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

The Army will kick off its new retention bonus system next month, using physical fitness scores, technical expertise and commander evaluations to determine a soldier’s payout to reenlist. “We were ...

State lawmakers might reduce funding for Running Start, a program that lets high school juniors and seniors take courses and earn credits at community and technical colleges. Running Start students ...

The now-viral X post from Meta AI security researcher Summer Yue reads, at first, like satire. She told her OpenClaw AI agent to check her overstuffed email inbox and suggest what to delete or archive ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...

Hey there, fellow coder! 😊 Ever typed java -version in your Command Prompt only to be hit with a frustrating "java is not recognized as an internal or external command"? You're not alone—this common ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.